Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 92 of 1725 for:    Recruiting, Not yet recruiting, Available Studies | Autoimmunity

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03884400
Recruitment Status : Not yet recruiting
First Posted : March 21, 2019
Last Update Posted : August 7, 2019
Sponsor:
Information provided by (Responsible Party):
iSpecimen Inc

Brief Summary:
This protocol seeks to assist biorepositories/biobanks in distributing their stored specimens and data to researchers that will actually utilize them to advance medicine and technology.

Condition or disease Intervention/treatment
Cancer Pregnancy Related Gastro-Intestinal Disorder Cardio-Respiratory Distress Women's Health: Endometriosis Autoimmune Diseases Nephritis Healthy Neuro-Degenerative Disease Procedure: Specimens obtained from surgical, phlebotomy or other non-invasive procedure

Detailed Description:

iSpecimen has built a partner network comprised of supplying institutions that have ethically acquired human biospecimens and created biorepositories/biobanks to store the specimens and data.

Many of these biorepositories have protocols allowing for the collection of their samples but require an additional IRB or ethics review for the distribution of their samples.

This protocol establishes a method of such supply sites to allow their specimens to be distributed and used for research via iSpecimen's technology and network of research clients.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000000 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: iSpecimen Network Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
Estimated Study Start Date : December 1, 2019
Estimated Primary Completion Date : December 31, 2029
Estimated Study Completion Date : March 1, 2030

Group/Cohort Intervention/treatment
Subjects who have provided consent for specimen collection
Re-consent will not be required. This protocol allows distribution of the specimens following the terms agreed to by the subject in the original consent.
Procedure: Specimens obtained from surgical, phlebotomy or other non-invasive procedure
Biospecimen Collection




Primary Outcome Measures :
  1. Distribution of Biospecimens From Biorepositories/Biobanks for Research Use [ Time Frame: 15 years ]
    The number of specimens and subjects distributed per disease will be measured and reported.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Diverse group of biorepositories with focus on cancer, neurodegenerative, pediatric, women's health and other cohorts.
Criteria

Inclusion Criteria:

  • Specimens and/or data from Biorepositories that have enrolled subjects that have provided consent for the specimens and de-identified data to be collected, stored and distributed.
  • Specimens from biobanks that have collected materials and de-identified data under a waiver of consent
  • Specimens from a biobank that meet the criteria for non human subject research under the common rule.

Exclusion Criteria:

  • Specimens and/or that have been obtained from subjects without informed consent, nor waiver of consent or that do not meet the criteria for non human subject research under the common rule.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03884400


Contacts
Layout table for location contacts
Contact: Emily Hubbard 2567970003 ehubbard@ispecimen.com
Contact: Jill Mullan 7813016688 jmullan@ispecimen.com

Locations
Layout table for location information
United States, Massachusetts
iSpecimen Not yet recruiting
Lexington, Massachusetts, United States, 02420
Contact: Emily Hubbard    256-797-0003    ehubbard@ispecimen.com   
Sponsors and Collaborators
iSpecimen Inc
Investigators
Layout table for investigator information
Principal Investigator: Chris Ianelli, MD, PhD iSpecimen Inc

Additional Information:
Layout table for additonal information
Responsible Party: iSpecimen Inc
ClinicalTrials.gov Identifier: NCT03884400     History of Changes
Other Study ID Numbers: ISPC-180828-DISTRIBUTION
First Posted: March 21, 2019    Key Record Dates
Last Update Posted: August 7, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Autoimmune Diseases
Intestinal Diseases
Gastrointestinal Diseases
Neurodegenerative Diseases
Endometriosis
Nephritis
Digestive System Diseases
Genital Diseases, Female
Kidney Diseases
Urologic Diseases
Immune System Diseases
Nervous System Diseases